AU2001236361A1 - Treatment of asthma with lfm analogues - Google Patents

Treatment of asthma with lfm analogues

Info

Publication number
AU2001236361A1
AU2001236361A1 AU2001236361A AU3636101A AU2001236361A1 AU 2001236361 A1 AU2001236361 A1 AU 2001236361A1 AU 2001236361 A AU2001236361 A AU 2001236361A AU 3636101 A AU3636101 A AU 3636101A AU 2001236361 A1 AU2001236361 A1 AU 2001236361A1
Authority
AU
Australia
Prior art keywords
lfm
analogues
asthma
treatment
lfm analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236361A
Inventor
Ravi Malaviya
Fatih M. Uckun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parker Hughes Institute
Original Assignee
Parker Hughes Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Institute filed Critical Parker Hughes Institute
Publication of AU2001236361A1 publication Critical patent/AU2001236361A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
AU2001236361A 2000-10-20 2000-10-20 Treatment of asthma with lfm analogues Abandoned AU2001236361A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/041328 WO2002034251A1 (en) 2000-10-20 2000-10-20 Treatment of asthma with lfm analogues

Publications (1)

Publication Number Publication Date
AU2001236361A1 true AU2001236361A1 (en) 2002-05-06

Family

ID=21742156

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236361A Abandoned AU2001236361A1 (en) 2000-10-20 2000-10-20 Treatment of asthma with lfm analogues

Country Status (2)

Country Link
AU (1) AU2001236361A1 (en)
WO (1) WO2002034251A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10311763A1 (en) * 2003-03-18 2004-10-07 Aventis Pharma Deutschland Gmbh Process for the preparation of 2-cyano-3-hydroxy-N- (phenyl) but-2-enamides
US8389757B2 (en) 2008-06-05 2013-03-05 Alembic Ltd. Process for preparing teriflunomide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695907B2 (en) * 1994-10-17 1998-08-27 Hoechst Pharmaceuticals & Chemicals K.K. Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
JP2002512216A (en) * 1998-04-17 2002-04-23 パーカー ヒューズ インスティテュート BTK inhibitors and methods for identification and use thereof

Also Published As

Publication number Publication date
WO2002034251A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2001270943A1 (en) Surgical instrument and method of using the same
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2002314466A1 (en) Withasol and methods of use
GB0112699D0 (en) Process for the preparation of prostglandins and analogues thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002366210A1 (en) Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
AU2001277278A1 (en) Method and system of providing competitive comparative terms to the user
AU2001247414A1 (en) Oligonucleotide analogues, methods of synthesis and methods of use
AU2002335085A1 (en) Angiopoietins and methods of use thereof
AU2001280179A1 (en) Production and use of octafluoropropane
AU2002231206A1 (en) Treatment of depression
AU2001260834A1 (en) The treatment of herpes
AU2001235363A1 (en) Mibefradil analogues and their use
AU5262200A (en) Arrangement in ventilatory treatment of the lungs
AU6406800A (en) SF3 promoter and methods of use
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001236361A1 (en) Treatment of asthma with lfm analogues
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
AU5812601A (en) Treatment of il-10 deficiencies